Pharma & Healthcare · United States
EyePoint Pharmaceuticals layoffs
EyePoint Pharmaceuticals cut about 53% of staff in Oct 2026.
Latest event: Oct 2026

People affected
N/A
Across tracked announcements
Announcements
1
Oct 2026 → Oct 2026
AI-attributed
0%
Of affected people
The short version
- None of these cuts was publicly blamed on AI.
- We track 227 employers in United States with layoffs since 2022.
Every round, newest first
- −Undisclosed(53% of workforce)
EyePoint is cutting about half its staff after its wet AMD drug failed a second Phase 3 trial.
Source: BioSpace
Common questions about EyePoint Pharmaceuticals
- How many people has EyePoint Pharmaceuticals laid off?
- EyePoint Pharmaceuticals has not said how many people it let go in the 1 round we track.
- When was the latest EyePoint Pharmaceuticals layoff?
- Oct 2026: about 53% of staff. EyePoint is cutting about half its staff after its wet AMD drug failed a second Phase 3 trial.
- Did EyePoint Pharmaceuticals blame AI for its layoffs?
- No. None of the 1 round we track was publicly tied to AI by EyePoint Pharmaceuticals or in credible reporting.
Working at EyePoint Pharmaceuticals, or somewhere like it?
Check your company against the 15 warning signs we saw before cuts like these, or see how exposed your own role is.
Part of the WorkforceSignal company directory, every event curated from public reporting with conservative AI attribution. See methodology.